Difference between revisions of "Combining-Gabapentin-Ziprasidone"

From Psychiatrienet
Jump to: navigation, search
(Created page with '{{Drugcombi | base = gabapentin | add = ziprasidone | info = * Ziprasidone is metabolized by CYP1A2 (minor) and CYP3A4.<ref>Bazire S; Psychotropic drug directory, 2007</ref> ...')
(No difference)

Revision as of 14:36, 8 June 2010

Gabapentin
Type moodstabilizer
Group anticonvulsant
links
ATC-code N03AX12
PubChem 3446
PubMed Gabapentin
Drugs.com gabapentin
Kompas (Dutch) Gabapentin
Wikipedia Gabapentin
Ziprasidone
Type Antipsychotic
Group Atypical AP
Other use Moodstabilizer
links
Medscape Ziprasidone
PubChem 60854
PubMed Ziprasidone
Wikipedia Ziprasidone

Adding ziprasidone to gabapentin.

Infobord.png General information
  • Gabapentin is eliminated unchanged by the kidney for 100%.
  • Ziprasidone is metabolized by CYP1A2 (minor) and CYP3A4.
  • Ziprasidone is metabolized by CYP1A2 (minor) and CYP3A4.[2]
  • This combination of drugs may have possible synergistic effects. There are no reports for pharmacokinetic drug interactions. However, the combination will have additional side effects. [3]
Eenrichtingbord.png Start ziprasidone
  • Start ziprasidone according to the general dosing advice.
Letopbord.png Cave
  • Central nervous system- and/or respiratory-depressant effects may be additively or synergistically increased in patients taking multiple drugs that cause these effects. [4]


The editors of psychiatrienet.nl take the greatest care to provide up-to-date and accurate information on this site. Nevertheless, mistakes and omissions cannot be entirely excluded. No rights devolve from the information provided. The editors and other providers of information to this site accept no responsibility for the content of this site or for the information provided therein; neither do they accept responsibility for possible damages which may derive from the use of the information on this site or from the linked sites. The editorial board accepts no responsibility for the content of the (linked) sites, for access to them, or for the products and services on these sites, nor for the occurrence of errors, viruses, and/or disruptions in service.